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ABSTRACT 
Aims: To 1) estimate predictors of first vs. second generation electronic cigarette (e-cigarette) choice;  
2) determine whether a second generation device was i) superior for reducing urge to smoke and 
withdrawal symptoms (WS) and ii) associated with enhanced positive subjective effects.  Design: 
Mixed effects experimental design.  Phase 1: reason for e-cigarette choice was assessed via 
questionnaire.  Phase 2: participants were randomly allocated to first or second generation e-cigarette 
condition.  Urge to smoke and WS were measured before, and 10mins after, taking 10 e-cigarette 
puffs.  Setting: University of East London, UK.  Participants:  97 smokers (mean age 26; SD 8.7; 54% 
female) Measurements:   Single item urge to smoke scale to assess craving; Mood and Physical 
Symptoms Scale (MPSS) to assess WS.  Subjective effects included: satisfaction, hit, ‘felt like smoking’ 
and ‘would use to stop smoking’ (Yes vs. No response).  Findings: Equal numbers chose each device 
but none of the predictor variables (gender, age, tobacco dependence, previous e-cigarette use) 
accounted for choice.  Only baseline urge to smoke/WS predicted urge to smoke/WS 10 minutes after 
use (B=0.38; P<0.001 and B=0.53; P<0.001). E-cigarette device was not a significant predictor.     Those 
using the second generation device were more likely to report satisfaction and use in a quit attempt 
(χ2=12.10, P=0.001 and χ2=5.53, P=0.02).  Conclusions:  First and second generation e-cigarettes 
appear to be similarly effective in reducing urge to smoke and WS during abstinence but second 
generation devices appear to be more satisfying to users.   
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INTRODUCTION 
Electronic cigarettes (e-cigarettes; also known as electronic nicotine delivery systems [ENDS] or 
personal vaporisers) are battery-powered devices that deliver nicotine in an aerosol of inhaled 
propylene glycol or glycerol.  Since e-cigarettes heat rather than burn, the production of toxins and 
carcinogens is far lower than from conventional tobacco smoking [1-3].   Following introduction into 
Europe and the US in 2006, e-cigarette use has become increasingly popular with sales in the US 
doubling each year from $20m in 2008 to $750m - $1bn in 2013.  In March 2014 Wells Fargo Securities 
estimated the total size of the US retail market at $2bn [4].  Current use by smokers in the UK increased 
from 3% in 2010 to 19% in 2014 [5] and similarly, in the US, from 3.3% in 2010 to 6.2% in 2011 [6].  E-
cigarettes, however, are the subject of furious public health debate.  Some advocate them as one of 
the greatest public health breakthroughs in tobacco control history with potential to save millions of 
smoking-related deaths [7,8]; opponents fear they could re-normalise smoking and appeal to non-
smokers, acting as a gateway to cigarette smoking [9,10].  
 
All e-cigarettes comprise a lithium battery, a cartridge containing the e-liquid, and an atomiser which 
heats the e-liquid to create the aerosol.  There is marked variability however, in visual appearance; 
some, commonly referred to as first generation devices, resemble tobacco cigarettes (cigalikes).  
These comprise low-capacity disposable or re-chargeable batteries and combined cartridges and 
atomisers (cartomisers).  Second generation devices resemble pens or gadgets and use larger batteries 
and fluid filled reservoirs (clearomisers or tanks), filled from bottles of e-liquid.  Third generation 
devices bear little resemblance to cigarettes, use larger-capacity batteries, replacement heating coils 
and wicks for atomizers, and adjustable and programmable power delivery.  Whilst early studies 
reported very little nicotine delivery from e-cigarettes [11,12], more recently, studies in experienced 
users have found measureable nicotine delivery (comparable to nicotine replacement therapy; NRT) 
[13,14] especially with newer generation devices [15].  
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 E-cigarette use (often referred to as vaping) resembles the act of smoking: the user holds the device 
and draws on it like a cigarette; the aerosol produced resembles smoke and is drawn into the lungs 
and exhaled like smoke; tobacco (or menthol) flavouring mimics the taste of tobacco smoke and first 
generation devices resemble cigarettes exactly.  Although nicotine is clearly a critical component of 
smoking addiction, a growing body of evidence points to the importance of non-nicotine factors.  For 
example, smokers enjoy the sensory and tactile components of smoking, including the hand-mouth 
activity, taste, smell and sensations in the respiratory tract [16].  Denicotinised cigarette smoking can 
alleviate nicotine withdrawal symptoms (WS) and craving [17,18] and is preferred over receiving 
nicotine intravenously [19].  Such sensorimotor cues likely act as conditioned reinforcers by virtue of 
their pairing with the primary reinforcer, nicotine, thus contributing to maintenance of tobacco 
addiction.  Replacing these cues as well as delivering nicotine may contribute to the popularity of e-
cigarettes among smokers [20].  Indeed, pilot work in our laboratory shows that in e-cigarette-naive 
smokers, visual similarity to cigarettes is important for craving reduction and symptom relief, and 
cigalike placebo devices can also be effective [21]. 
 
Mimicking the visual and sensorimotor characteristics of smoking is likely to be more important for 
some smokers than others.  For example, it is possible that more dependent smokers or those with a 
longer smoking history might be more responsive to cigarette-like cues, given the length of the 
conditioning process.  Gender differences are also documented; compared to men, the smoking 
behaviour of women may be more influenced by non-nicotine stimuli associated with smoking such 
as the look, touch and feel of cigarettes [22].  In relation to e-cigarette use, placebos have been shown 
to be as effective as nicotine containing devices for reducing craving and nicotine-related WS in 
women but not in men [21].  Whether it is important for an e-cigarette to resemble a conventional 
cigarette, and for whom, is important if the widespread use of e-cigarettes, especially cigalikes (first 
generation devices) undermines tobacco control efforts and makes smoking socially acceptable.  
Nevertheless, whilst first generation cigalike devices may be appealing to smokers, especially those 
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with little previous experience of e-cigarettes (as found in our pilot work), regular e-cigarette users 
more commonly report using second and third generation devices [23,24].  Preliminary evidence 
based on retrospective reporting suggest that such devices may be superior for smoking cessation [25] 
and in experienced exclusive  e-cigarette users, better than first generation devices for blood nicotine 
delivery and alleviation of craving [15].     
 
The aims of the current study were: 1) to determine whether gender, cigarette dependence, previous 
e-cigarette use and age predict e-cigarette choice (first generation cigalike vs. a second generation 
device) in e-cigarette-inexperienced smokers (phase 1) and, 2) to determine whether a second 
generation device is superior to a first generation device for i) reducing urge to smoke and nicotine-
related WS and ii)  enhancing subjective effects (e.g. hit and satisfaction; phase 2). In abstinent 
smokers (between 1 and 12 hours), craving and WS reduction have previously been reported following 
use of both first [11,12,21] and second [26] generation devices, but none have directly compared the 
two in non e-cigarette-using smokers.  Determining for whom cigarette-like appearance might be 
important and assessing their appeal and effectiveness against second generation cigarette-dissimilar 
devices may have clinical utility as well as marketing and regulatory implications.   
 
METHOD 
Participants 
One hundred participants were recruited over a three month period.  In the absence of previous work 
examining predictors of e-cigarette choice, we used Green’s (1991) rule of thumb (cited in Tabachnick 
& Fidell, 2007) [27] to determine the number of participants required for phase 1 (N ≥ 50 +8(m) where 
m is the number of IVs) assuming a medium-sized relationship between the IVs and DVs, α = 0.05 and 
four predictor variables.  50 + (8) (4) = 82 which we rounded up to 100 to allow for drop out.   For 
phase 2, this sample size provides in excess of 99% power to detect an effect of e-cigarette device (1st 
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vs. 2nd generation) on craving at α = 0.05 based on the work of Farsalinos and colleagues [15] who 
observed a very large effect size (Cohen’s d = 1.26) when comparing craving to vape between a first 
and a new generation device.   
Participants responded to advertisements (online and on campus) at the University of East London by 
e-mailing or telephoning the researcher.  All were daily smokers (smoke >1 cigarette a day for at least 
the last year), abstinent from smoking/nicotine use for at least one hour (consistent with [21]) and 
were not currently using e-cigarettes.  Exclusion criteria included pregnancy/suspected pregnancy, 
breast-feeding, serious medical condition (i.e. heart disease or recent stroke or neurological 
diagnosis).   Two participants who failed to comply with the study puffing procedures (ten three-
second puffs with a 30 second inter-puff interval) and one who was a non-daily smoker were 
withdrawn.  Thus, all analyses were conducted on ninety-seven participants, 53 (54%) female, 79 
(81%) students, aged between 18 and 60 years old (M = 25.78, SD = 8.69).  Fifty four participants (56%) 
had previously tried an e-cigarette (mean 15 times, SD: 36; range 1 – 180 times) with 82% having used 
on fewer than 5 occasions.  The ethnic composition of the sample was: White (60%), Black African and 
Caribbean (11%), Asian (10%), Mixed Race (8%), Chinese (1%) and Other (9%).   
 
Measures 
E-Cigarettes: 
In phase one, participants were presented with two e-cigarettes: a first generation E-30 rechargeable 
cartomiser device purchased from E-Lites, chosen because of its clear visual resemblance to a tobacco 
cigarette (cigalike), and a second generation, stainless steel eGo-T purchased from Joyetech which 
resembled a silver fountain pen.   
In phase two, the same eGo-T second generation device was used but the first generation 
rechargeable device was replaced with a disposable cigarette-like device purchased from Totally 
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Wicked (the disposable device represents the simplest device on the market and requires no charging 
or changing of cartridges).  18mg/ml nicotine strength, tobacco flavoured cartridges were used in both 
cases.    
 
Questionnaires: 
Cigarette Dependence was assessed using the Fagerström Test of Cigarette Dependence (FTCD) [28], 
a six-item questionnaire providing an overall dependence score ranging from 0 (low dependence) to 
10 (high dependence).   
Craving and withdrawal symptoms (WS) were measured using the Mood and Physical Symptoms Scale 
(MPSS) [29].  Dimensions include ‘urge to smoke’ right now, measured on a seven-point rating scale 
(scores range from 1 to 7: ‘Not at all strong’ to ‘Extremely strong’) and ‘depressed mood’, ‘irritability’, 
‘anxiety’, ‘restlessness’, ‘hunger’ and ‘inability to concentrate’, each measured using a five-point rating 
scale (scores range from 1 to 5: ‘Not at all’ to ‘Extremely’).  Individual item scores are summed to 
provide an overall total WS score (possible range: 6 – 30). 
The main reason for first versus second generation e-cigarette choice was gathered via the single 
question: ‘Which factor played the most important role in choosing the e-cigarette?’ with the 
following options: ‘Because it resembles a conventional cigarette’, ‘Because it does not resemble a 
conventional cigarette’, ‘Because it is stylish’, ‘Because I thought it would be good for delivering 
nicotine’.  Participants could select only one option. 
Subjective effects relating to e-cigarette use were each rated on a three-point scale: satisfaction (not 
at all, fairly, very), hit (no, partly, yes), whether the e-cigarette felt like smoking (not at all, partly, yes) 
and whether participants would use the e-cigarette in a quit attempt (no, maybe, yes).  For analytical 
simplicity, responses were then re-coded into two categories (i.e. no vs. yes with the two positive 
categories combined). 
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Socio-demographic information (including age, gender, ethnicity, occupation and highest 
qualification) and further data on smoking habits (e.g. cigarettes per day; CPD) and e-cigarette 
awareness and use were also recorded. 
 
 
 
Procedure 
Phase 1: 
Following informed consent and a carbon monoxide (CO) breath test, participants completed the 
baseline socio-demographic, smoking-related, urge to smoke and WS questionnaires.  Participants 
were then presented with two e-cigarettes, a first-generation cartomiser device which resembled a 
cigarette in shape, size and colour (cigalike), and a second generation eGo device (counterbalanced 
for left vs. right positioning).  They were asked: ‘If you were to try one of these e-cigarettes today, 
which one would you choose?’ After indicating their choice, participants then completed a 
questionnaire explaining their choice.  
 
Phase 2: 
Participants were then randomly allocated (via coin toss) to either a first generation cigalike or second 
generation (eGo) e-cigarette group (regardless of choice in phase 1).  A new disposable device was 
used for each participant in the first generation group and mouth-pieces/cartridges were replaced and 
re-filled for each participant in the second generation group.   Instructions were given to participants 
on how to use the e-cigarette (i.e. push and hold down button to activate, whilst drawing on the e-
cigarette). Participants were also instructed to start and stop puffing only upon the researcher’s verbal 
signal. Participants were instructed to take ten puffs each of three-second duration with a thirty-
second inter-puff interval (IPI).  The original intention was to use a longer four second puff duration 
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(as recommended by [30]), however, during a pilot study it became evident that the four-second puff 
duration was too long for the cigalike device, producing over-heating and coughing. Consequently, 
puff length was reduced to three seconds for both conditions.  After 10 minutes, participants again 
rated their urge to smoke and WS and completed the subjective effects questionnaire.  Participants 
were then debriefed and given a disposable e-cigarette in compensation for their time.  The study was 
fully approved by the University of East London’s ethics committee.   
 
 
Statistical Analysis 
For phase 1, logistic regression (backwards likelihood ratio method) was used to generate odds ratios 
(OR) for selecting the first generation cigalike device associated with each of the predictor variables i) 
gender, ii) cigarette dependence (as measured by the FTCD),  iii) previous e-cigarette use (any vs. no 
use) and age.  For phase 2, multiple regression (backwards likelihood ratio method) was used to assess 
the effect of e-cigarette device (1st vs 2nd generation) on the dependent variables i) urge to smoke and 
ii) MPSS scores.  Baseline urge to smoke/MPSS scores, gender, prior e-cigarette use and preference 
for first vs. second generation device (taken from phase 1 of the study) were entered as covariates.  
 
Subjective effects (satisfaction, hit, felt like smoking and would use to quit smoking) were subjected 
to 2x2 (yes vs. no) chi square tests.  An alpha value of P < 0.05 was accepted as cut off for statistical 
significance.      
 
RESULTS 
Phase 1 
Equal numbers of participants selected the first (N=48; 49.5%) versus the second (N=49; 50.5%) 
generation device.  Evaluation of reasons given for choice confirmed that most of those who chose 
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the cigalike device did so because it resembled a conventional cigarette (83%).  Other reasons were, 
‘because it is stylish’ (8%) and ‘because I thought it would be good for delivering nicotine’ (8%).  
Reasons for selecting the second generation device were: ‘it does not resemble a conventional 
cigarette’ (45%), ‘it is stylish’ (45%), ‘I thought it would be good for delivering nicotine (6%) and ‘other’ 
(4%).     
The four predictor variables (gender, previous e-cigarette use, cigarette dependence and age) 
collectively explained 11% of the variance in e-cigarette choice in the initial model (χ2= 11.13, df = 8, 
P = 0.19; Nagelkerke pseudo R2 = 0.06).  Cigarette dependence was the only variable retained in the 
final model which accounted for 14.67% of the variance in e-cigarette choice (and was statistically 
better than the previous model: χ2= 14.67, df = 5, P = 0.01; Nagelkerke pseudo R2 = 0.04) although 
FTCD was not a statistically significant predictor of e-cigarette choice (see Table 3).   
 
Phase 2 
For urge to smoke, the initial model with all five variables (e-cigarette device, baseline urge to smoke 
gender, prior e-cigarette use and phase 1 device preference) collectively accounted for 21.9% of the 
variance in urge to smoke following e-cigarette use (F5,91 = 5.12, P < 0.001).  E-cigarette device 
however, did not emerge as a significant predictor and the final model retained baseline urge to smoke 
only, accounting for 17.6% of the variance (F1,95 = 20.32, P < 0.001). See Table 3. 
Similarly for WS, the initial model (e-cigarette device, baseline WS, gender, prior e-cigarette use and 
phase 1 device preference) significantly predicted WS following e-cigarette use (F5,88 = 11.14, P < 
0.001), accounting for 38.8% of the variance in WS.  Again, e-cigarette device was not a statistically 
significant predictor and only baseline WS was retained in the final model (F = 56.99, P < 0.001) 
accounting for 38.3% of the variance.  See Table 4.   
In relation to subjective effects, compared to those using the first generation device, significantly more 
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participants using the second generation device stated that the e-cigarette was satisfying (χ2 (1) = 
12.10, P = 0.001), although there was no significant difference between groups for ratings of hit (χ2 (1) 
= 2.18, P = 0.14).  Those in the second generation group were also more likely to state that they would 
use the e-cigarette in a cessation attempt (χ2 (1) = 5.53, P = 0.02) and that the e-cigarette ‘felt like 
smoking’, although the latter did not reach statistical significance (χ2 (1) = 3.16, P= 0.08). See Table 4.  
The groups did not differ on any other demographic or smoking related variable (Table 4).  
 
 
DISCUSSION 
This is the first study to examine e-cigarette choice, and to directly compare a first versus second 
generation device on urge to smoke, WS and subjective effects, in e-cigarette-inexperienced smokers.  
Half of regular smokers chose a first generation (cigalike) rather than a second generation device but 
none of the independent variables: gender, prior e-cigarette use, cigarette dependence or age, 
predicted device choice. First and second generation devices were equally effective in reducing urge 
to smoke and WS, although the latter was rated as more satisfying, and more likely to be used in a 
quit attempt.   
 
When presented alongside a second generation eGo device, half of all regular smokers in this sample 
selected the first generation, cigalike device in phase 1.  The majority (83%) stated the reason was its 
resemblance to a tobacco cigarette, indicating that for many people, visual similarity to a cigarette is 
an important determinant of initial e-cigarette device selection.  Cigarette related cues such as visual 
appearance, sight/smell of smoke, or manipulation of a cigarette in the hand, over the course of a 
smoker’s history, are repeatedly paired with the primary reinforcer, nicotine.  Via this process of 
classical conditioning, such cues can become powerful secondary reinforcers, capable of providing 
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some pleasure and alleviation of craving and WS themselves [31] which may explain some smoker’s 
preference for a cigarette-like device.  By contrast, almost half (45%) of those selecting the second 
generation device did so because it did not resemble a cigarette.  Although we did not probe further, 
this may be because it cannot be confused with a conventional cigarette by observers who disapprove 
of smoking.  Alternatively, it may be because cigarette related cues can also act as conditioned stimuli 
[32], increasing craving [33] and the probability of smoking [34].  Cigarette-like cues clearly have 
different meanings for different individuals.  Although we did not measure the importance of self-
rated smoking-related cues here, elsewhere, higher quit rates have been observed among smokers 
using a cigarette-shaped non-nicotine inhalator only in those scoring high on the behavioural (non-
nicotine) aspects of smoking [35].    
 
None of the predictor variables:  gender, prior e-cigarette use, cigarette dependence or age, were 
significant predictors of e-cigarette choice. We have previously reported, in a sample of 1347 regular 
e-cigarette users, that females were more likely to use first, and males to use second generation 
devices [23] although this was not reflected in the choices made by smokers here.  Nevertheless, the 
previous study was based on actual use rather than visual appearance alone, as in the current study.  
Given the evidence that many regular users move on from first to second or third generation devices 
[23,25,36] we also predicted that those who had some experience of using an e-cigarette in the past 
would be more likely to opt for a second generation device.  That prior e-cigarette use was not a 
significant predictor here may reflect the fact that most users (82%) had previously used an e-cigarette 
on fewer than five occasions.    
 
In phase 2, only baseline urge/WS predicted the decline in urge to smoke and WS following e-cigarette 
use; the first and second generation devices were equally effective, and this effect was independent 
of prior e-cigarette use, device preference and gender.  No other studies have directly compared first 
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versus second generation devices in e-cigarette-inexperienced smokers, although Farsalinos and 
colleagues [15] have reported a greater reduction in e-cigarette craving and WS as well as higher blood 
nicotine levels in experienced users using a third, compared with a first generation device.   The 
equivalency between devices in terms of alleviating urge to smoke and WS here, may reflect effective 
nicotine delivery in this product, its ability to replace some of the visual secondary reinforcing effects 
of smoking (by virtue of its resemblance to a cigarette) or both.  Although one cannot distinguish 
between these possibilities, in support of the former, the first generation disposable e-cigarette from 
Totally Wicked selected here, has subsequently been associated with very good nicotine release to 
vapour compared with similar devices [37].  Thus whilst first generation devices are clearly capable of 
alleviating WS to a level commensurate with second generation devices, these findings cannot be 
generalised to the hundreds of other e-cigarettes on the market.    
 
Despite comparable efficacy for the alleviation of urge to smoke and WS, more participants in the 
second generation group rated the device as satisfying, and perhaps consequently, stated that they 
would be more likely to use it in a quit attempt.   By contrast, there was no difference between groups 
for subjective experience of hit.  Examination of further comments provided by participants reveals 
that the second generation device was generally described as ‘smoother’ and the first generation 
device as ‘harsher on the throat’.  This might account for the higher levels of satisfaction and likelihood 
of use for quitting among those using the former.  
 
There are a number of study limitations, most notably, the young, predominantly student sample with 
low cigarette dependence (mean FTCD 2.7); it is possible that, with more highly dependent smokers, 
differences between groups may emerge.  Secondly, the smokers tested were only one-hour abstinent 
and therefore may not have been experiencing strong urges to smoke which may have reduced the 
magnitude of any reduction in urges/WS following e-cigarette use.  Nevertheless, the mean baseline 
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urge to smoke score (3.71, range: 1-7) is comparable with that observed in a sample of 145 smokers 
abstinent for 10-12 hours (M = 3.96, range: 1-7; [32]) and was sufficiently high to produce a significant 
reduction following e-cigarette use.   Finally, subjective measures were taken 10 minutes after 10 puffs 
on the e-cigarette.  Whether comparable reduction in urge to smoke/WS continue over a longer time 
period remains unclear.  At this time point (10 mins after 10 puffs), although measurable nicotine 
levels from the e-cigarette will have reached the blood [13],  blood nicotine levels are still likely to be 
rising and it may be that significant differences between groups might emerge after 20/30 minutes 
[21].   
 
Although replication in a more highly dependent sample of abstinent smokers with a longer follow up 
time after e-cigarette use is essential, we can tentatively conclude that: i) cigarette-like appearance is 
important for many smokers when choosing an e-cigarette device although individual factors 
predicting choice remain unclear; ii) first generation cigalike devices  have the ability to be as effective 
as second generation devices for reducing cigarette urges and WS; iii) second generation devices may 
be more satisfying to use which may explain why more people report successfully quitting with them 
[25].   Although there is concern that first generation cigalike products in particular may re-normalise 
smoking, they clearly appeal to many smokers and compare favourably to second generation devices 
for craving/WS alleviation at least in the short term.  Whether this effect is maintained over a longer 
term quit attempt by comparison with later generation devices remains to be determined. 
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 TABLES: 
Table 1: Predictors of first generation e-cigarette choice (backwards likelihood ratio method) 
 B SE Wald df P OR 95% CI for OR 
  Lower         Upper 
Step 1         
Gender -0.18 0.43 0.18 1 0.68 0.84 0.36 1.94 
Prior e-cig use 0.24 0.43 0.33 1 0.57 1.28 0.55 2.94 
FTCD -0.15 0.10 2.18 1 0.14 0.86 0.70 1.05 
Age -0.03 0.03 0.94 1 0.33 0.97 0.92 1.03 
Constant 0.13 1.30 0.009 1 0.92 1.13   
         
Step 2 
 
        
Prior e-cig use 0.26 0.42 0.37 1 0.54 1.29 0.56 2.97 
FTCD -0.14 0.10 2.03 1 0.15 0.87 0.71 1.06 
Age -0.03 0.03 0.94 1 0.33 0.97 0.92 1.03 
Constant 0.91 0.71 1.61 1 0.20 2.48   
         
Step 3         
FTCD -0.15 0.10 2.32 1 0.13 0.86 0.71 1.04 
Age -0.02 0.03 0.82 1 0.36 0.98 0.93 1.03 
Constant 0.99 0.70 2.02 1 0.16 2.70   
         
Step 4         
FTCD -0.17 0.10 3.07 1 0.08 0.85 0.70 1.02 
Constant 0.43 0.33 1.73 1 0.19 1.54   
         
OR = Odds Ratio (refers to odds of selecting the first generation (cigalike) device); FTCD = Fagerström Test of Cigarette Dependence 
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Table 2: Predictors of urge to smoke following e-cigarette use (backwards likelihood ratio method) 
 B SE β t P 95% CI for B 
Lower          Upper 
Step 1        
E-cig device 0.34 0.27 0.12 1.24 0.22 -0.20 0.87 
Baseline urge 0.36 0.09 0.40 4.28 0.00 0.19 0.53 
Gender -0.34 0.27 -0.12 -1.27 0.21 -0.87 0.19 
Prior e-cig use -0.34 0.27 -0.12 -1.25 0.22 -0.88 0.20 
Device preference 0.16 0.27 0.06 0.59 0.56 -0.38 0.70 
Constant 0.94 0.71  1.31 0.19 -0.48 2.35 
        
Step 2        
E-cig device 0.34 0.27 0.12 1.27 0.21 -0.19 0.87 
Baseline urge 0.35 0.08 0.40 4.26 0.00 0.19 0.52 
Gender -0.32 0.27 -0.11 -1.22 0.23 -0.85 0.20 
Prior e-cig use -0.34 0.27 -0.12 -1.27 0.21 -0.88 0.19 
Constant 1.03 0.69  1.48 1.41 -0.35 2.40 
        
Step 3        
E-cig device 0.37 0.27 0.13 1.40 0.17 -0.16 0.90 
Baseline urge  0.36 0.83 0.40 4.31 0.00 0.19 0.53 
Prior e-cig use -0.37 0.27 -0.13 -1.36 0.18 -0.90 0.17 
Constant 0.47 0.52  0.90 0.37 -0.57 1.51 
        
Step 4        
E-cig device 0.31 0.26 0.11 1.17 0.25 -0.22 0.83 
Baseline urge 0.37 0.83 0.42 4.46 0.00 0.21 0.54 
Constant 0.32 0.51  0.62 0.53 -0.70 1.34 
        
Step 5        
Baseline urge 0.38 0.08 0.42 4.51 0.00 0.21 0.54 
constant 0.77 0.34  2.29 0.02 0.10 1.44 
E-cig device = 1st vs. 2nd generation e-cigarette; Baseline urge = Baseline urge to smoke; Device preference: 1st vs 2nd generation from phase 1. 
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Table 3: Predictors of withdrawal symptoms (WS) following e-cigarette use (backwards likelihood ratio 
method) 
 B SE β t P 95% CI for B 
Lower          Upper 
Step 1        
E-cig device -0.32 0.51 -0.05 -0.61 0.54 -1.34 0.71 
Baseline WS 0.54 0.07 0.63 7.40 0.00 0.39 0.68 
Gender 0.17 0.52 0.03 0.32 0.75 -0.86 1.19 
Prior e-cig use 0.01 0.52 0.01 0.01 0.99 -1.02 1.03 
Device preference 0.22 0.51 0.04 0.44 0.66 -0.79 1.24 
Constant 3.55 1.49  2.38 0.02 0.59 6.52 
        
Step 2        
E-cig device -0.31 0.50 -0.05 -0.32 0.53 -1.31 0.69 
Baseline WS 0.54 0.07 0.63 7.46 0.00 0.39 0.68 
Gender 0.17 0.51 0.03 0.34 0.75 -0.85 1.19 
Device preference 0.22 0.51 0.34 0.44 0.66 -0.79 1.23 
Constant 3.55 1.48  2.40 0.02 0.61 6.50 
        
Step 3        
E-cig device -0.33 0.50 -0.06 -0.67 0.51 -1.32 0.66 
Baseline WS 0.53 0.07 0.62 7.53 0.00 0.39 0.67 
Device preference 0.24 0.50 0.04 0.47 0.64 -0.76 1.24 
Constant 3.87 1.12  3.45 0.00 1.89 6.14 
        
Step 4        
E-cig device -0.33 0.50 -0.05 -0.66 0.51 -1.31 0.66 
Baseline WS 0.53 0.07 0.62 7.55 0.00 0.39 0.67 
Constant 4.02 1.07  3.75 0.00 1.89 6.14 
        
Step 5        
Baseline WS 0.53 0.07 0.62 7.55 0.00 0.39 0.67 
constant 3.55 0.81  4.41 0.00 1.96 5.15 
E-cig device = 1st vs. 2nd generation e-cigarette; Baseline urge = Baseline urge to smoke; Device preference: 1st vs 2nd generation from phase 1. 
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Table 4: Smoking-related/demographic variables and positive subjective effects of the e-cigarette by 
condition (first vs. second generation device) 
 1st generation  
(cigalike) 
N = 46 
2nd generation 
(e-Go) 
N = 50 
 
  
 
 
N (%) N (%) 
 
χ2 P 
Gender: female 28 (60) 25 (50) 0.90 0.34 
Occupation: student 38 (81) 41 (82) 0.02 0.88 
Education: A-level + 42 (89) 44 (88) 1.66 0.65 
Ethnicity: European 26 (53) 32 (64) 2.61 0.76 
Prior e-cig use: Yes 22 (47) 32 (64) 2.90 0.09 
 
Satisfying: Yes  32 (67) 49 (94) 12.32 0.00 
Hit: Yes 36 (75) 46 (88) 3.06 0.08 
Use to Quit: Yes 38 (79) 50 (96) 6.82 0.01 
Felt like smoking: yes 37 (77) 47 (90) 3.29 0.07 
     
  
Mean (SD) 
 
Mean (SD) 
 
 
t  
 
P 
Age 25 (7.45) 26 (9.21) -0.57 0.57 
CO level 9.37 (5.30) 10.54 (5.11) -1.09 0.28 
Years smoked 7.91 (7.30) 9.44 (8.72) -0.93 0.35 
CPD 10.30 (5.23) 11.32 (3.69) -1.13 0.26 
FTCD 2.62 (2.46) 2.80 (1.95) -0.40 0.69 
     
CPD = Cigarettes Per Day; FTCD = Fagerström Test of Cigarette Dependence 
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